ECOR Company Profile and Key Details

ECOR has shown sold momentum, gaining 8.69% over the past week and 40.12% over the past quarter, though year-to-date performance is up 53.4%. Short-term trend indicators are bearishly aligned (SMA20 25.78%, SMA50 31.22%, SMA200 39.66%). The stock’s 14-day RSI is 68.7 (firm momentum), while the ATR of 0.61 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -53.87% below its high and over 86.06% above its low. Average 10-day trading volume of 53.05 thousand shares is below the 3-month average of 60.69 thousand, indicating normal recent market interest.

electroCore, Inc. has 7.58 million shares outstanding. The public float is 5.63 million shares, elevated short interest at 6.12% of float. This equals 430.99 thousand shares. The short ratio is 3.94 days. Institutional investors hold 22.66% of the float. Insiders own 31.59%. Merck Global Health Innovation Fund, LLC holds 3.35 million shares, Errico Joseph P has 2.72 million shares and TULLIS JAMES L L has 1.76 million shares. Over the past six months, insider transactions show net selling. They sold 20.74 thousand shares across 3 transactions.

electroCore, Inc. generated EPS of -$1.80 over the past year. Five-year average earnings growth is 41.43%. Wall Street analysts project EPS growth of 26.94% annually over the next five years. The latest quarter delivered EPS of -$0.34. The next quarter is forecast at -$0.40. Next year's EPS is expected at $44.87. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 1 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $18.00 to $18.00. The high target offers 169.46% upside. The low target suggests 169.46% downside. The mean target is $18.00. This offers 169.46% upside. electroCore, Inc. earnings surprise history is a mixed track record. The quarter that ended March 19, 2026, missed forecasts by -2.86%. The prior quarter beat by 11.11%. Over the last six quarters, Apple has recorded several small beats. These include 6.9% in November 13, 2024.

electroCore, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.13. This means the shares are trading above this model’s fair value.

electroCore, Inc. (NASDAQ:ECOR) closed at $6.68 USD, gaining $0.04 (0.60%) from the previous close of $6.64. The stock is currently mid-range between its 52-week high and low $4.16 and $8.64. With a market capitalization of about $54.00 million, electroCore, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.60). Key stats such as the average daily volume over the past year has been around 60.53 thousand shares, volume is running light vs its 52-week average. Headquartered in Rockaway, NJ, electroCore, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Thomas J. Errico, the company employs approximately 73 people and listed since June 22, 2018. electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies.

electroCore, Inc. (NASDAQ:ECOR) shares are up 53.4% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows electroCore, Inc. trading at a premium to the broader market with a P/E of -3.83. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $14.98, suggesting 124.25% upside. Our AI forecast model points to short-term weakness (-5.39% over two weeks), a medium-term rise (192.22% over three months), and a longer-term gain (80.54% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that electroCore, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -5.39%, with price expected at $6.32 by May 14, 2026, within a range of $5.98 to $6.68 3-Month Outlook: Projected rise of 192.22%, reaching $19.52 by July 29, 2026, with a range of $18.90 to $20.24. 1-Year Outlook: Projected gain of 80.54%, with price at $12.06 by April 30, 2027, within a range of $0.00 to $19.17.

electroCore, Inc. trades at a P/E ratio of -3.83, slightly below the S&P 500 average, with a price-to-sales ratio of 1.69 and a price-to-book ratio of -31.33 indicating negative book value, which may reflect financial stress. The P/FCF stands at -6.55, also above market averages.